
Cats May Help Develop Treatment For Dementia, Alzheimer's In Humans: Study
Scientists at the University of Edinburgh in the UK discovered a build-up of the toxic protein amyloid-beta in the brains of cats with the condition -- one of the defining features of Alzheimer's disease.
Many older cats develop dementia, leading to behavioural changes such as increased vocalisation -- or meowing -- confusion and disrupted sleep -- symptoms similar to those seen in people with Alzheimer's disease.
“The findings offer a clearer picture of how amyloid beta may lead to age-related brain dysfunction and memory loss in cats,” said Robert I. McGeachan, corresponding author, from the Centre for Discovery Brain Sciences at the varsity.
“Scientists studying Alzheimer's disease in the past have relied heavily on genetically modified rodent models. Rodents do not naturally develop dementia, and studying cats with dementia has the potential to advance knowledge and help develop treatments for both cats and people,” he added.
The team examined the brains of 25 cats of different ages after they had passed away, including those with signs of dementia.
Powerful microscopy images revealed a build-up of amyloid-beta within the synapses -- connections between brain cells -- of older cats and cats with dementia.
Synapses allow the flow of messages between brain cells and are vital to healthy brain function. Their loss strongly predicts reduced memory and thinking abilities in humans with Alzheimer's disease, according to the results published in the European Journal of Neuroscience.
The research team also found evidence that astrocytes and microglia -- types of support cells in the brain -- engulfed or 'ate' the affected synapses. This process, called synaptic pruning, is important during brain development but can contribute to synapse loss in dementia.
The findings will not only help to understand and manage dementia in cats but, given their similarities, could also contribute to the development of future treatments for people with Alzheimer's disease, the team said.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- VUBE Exchange Announces Unified Account Integration Across VUBE Pro, VUBE Plus, And VUBE Max
- Fitell Corporation Launches Solana (SOL) Digital Asset Treasury With $100M Financing Facility, With Focus On Yield And On-Chain Defi Innovation
- Meanwhile, Bitcoin Life Insurer, Secures $82M To Meet Soaring Demand For Inflation-Proof Savings
- Edgen Launches Multi‐Agent Intelligence Upgrade To Unify Crypto And Equity Analysis
- The Bitcoin Way Launches Panama Discovery Trip - A Premium 3-Day Plan B Experience
- Seoul Exchange, One Of Only Two Licensed Platforms For Unlisted Securities, Will Exclusively Use Story To Settle Tokenized Rwas
Comments
No comment